PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-42.32%
Negative revenue growth while Insurance - Life median is -0.09%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-42.32%
Negative gross profit growth while Insurance - Life median is -0.21%. Seth Klarman would suspect poor product pricing or inefficient production.
19.82%
Positive EBIT growth while Insurance - Life median is negative. Peter Lynch might see a strong competitive advantage in operations.
19.82%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
49.10%
Positive net income growth while Insurance - Life median is negative. Peter Lynch would view this as a notable competitive advantage.
49.07%
Positive EPS growth while Insurance - Life median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
49.11%
Positive diluted EPS growth while Insurance - Life median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.75%
OCF growth of 13.75% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
13.75%
FCF growth near Insurance - Life median of 13.75%. Charlie Munger could consider this standard for the industry’s capex cycle.
31.18%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 24.31%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
27.76%
5Y revenue/share growth 1.25-1.5x Insurance - Life median of 21.06%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
14.06%
3Y revenue/share growth 50-75% of Insurance - Life median of 19.99%. Guy Spier might worry about a waning short-term advantage.
89.81%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 35.00% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
155.57%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 29.36%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
625.32%
3Y OCF/share growth > 1.5x Insurance - Life median of 28.59%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
257.25%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 45.38% over a decade. Joel Greenblatt might see a standout compounder of earnings.
96.76%
5Y net income/share CAGR > 1.5x Insurance - Life median of 30.27%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
181.17%
3Y net income/share CAGR > 1.5x Insurance - Life median of 23.25%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
76.60%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 40.07% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
67.08%
5Y equity/share CAGR > 1.5x Insurance - Life median of 38.53%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
10.06%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.27%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
-0.58%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
0.37%
Positive BV/share change while Insurance - Life median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-0.91%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-11.42%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.